ARCHIVES

Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review.

This article is from The Cancer Letter archive.

Vol. 29 No. 42 | November 14, 2003

Download PDF Visit The Full Archive

Related Articles

Nutrition May Get An Extra 44 Million In FY 1979; Program Announcement Describes Opportunities

September 22, 1978

Cancer Telethon Attracts Small Audience, Generates Expectations-And Questions.

September 12, 2008

In Brief: Michael Friedman to Retire as CEO of City of Hope

March 1, 2013

NCI CTEP Approved Trials For the Month of March

March 29, 2013

NCI Offers Bibliography On Risk Communication.

March 23, 2001

Amgen’s Kepivance Approved For Severe Oral Mucositis

January 28, 2005